Funding · Company
Quanta Therapeutics, Inc.
South San Francisco, CABiotech & Pharma
Quanta Therapeutics, Inc. of South San Francisco, CA has disclosed $146M across 3 Form D offerings filed with the SEC between Nov 3, 2021 and Jun 24, 2026.
$146M
Total disclosed
3
Form D offerings
2018
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$76M
Form D · Jun 24, 2026 ↗
Q2 2026
· 1 amendment, first filed May 25, 2023
· target $89M
$40M
Form D · Nov 3, 2021 ↗
Q4 2021
· target $70M
Filing details
HeadquartersSouth San Francisco, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2018SEC CIK0001891891Offerings on file3
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →